Back to results
US 2008/0306036 A1Published application
Triphenylethylene Compounds Useful as Selective Estrogen Modulators
OwnerSubba Reddy Katamreddyinventor
Life of this patent
Estimating the term…
Abstract
Triphenylethylene compounds of formula (I) are provided. The compounds are particularly useful for selective estrogen receptor modulation.
Claims18
A compound of Formula I
- or a pharmaceutically acceptable salt or solvate thereof, wherein
- R1 is selected from the group consisting of C1-C6 alkyl and C1-C6 haloalkyl;
- each R2 is the same and selected from the group consisting of —OH, halogen, C1-C4 alkoxy, —S—R6, —SO—R6, and —SO2—R6;
- each R3 is the same and selected from hydrogen, —OH, C1-C6 alkyl, halogen, C1-C6 alkoxy, and C1-C6 haloalkyl;
- R4 is selected from —O—Ra—R8;
- R5 is selected from hydrogen, —OH, C1-C6 alkyl, halogen, C1-C6 alkoxy, and C1-C6 haloalkyl;
- Ra is selected from C1-C6 alkylene;
- R6 is a substituted or unsubstituted C1-C6 alkyl group;
- R8 is selected from NR9R10;
- and
- R9 and R10 are independently selected from H, C1-C6 alkyl, hydroxy (C1-C6) alkyl, and methoxy (C1-C6) alkyl, or R9 and R10 together with the nitrogen atom to which they are attached form a 4-8 membered heterocycle, optionally substituted with one or more halogen and/or one or more C1-C6 alkyl;
- with the proviso that R4 is —O—CH2—CH2—NCH3CH3 only if R5 is C1-C6 alkoxy.
9 more elements
A compound of Formula I
- or a pharmaceutically acceptable salt or solvate, or physiologically thereof, wherein
- R1 is selected from the group consisting of C1-C6 alkyl and C1-C6 haloalkyl;
- each R2 is —OH;
- each R3 is hydrogen;
- R4 is selected from —O—Ra—R8;
- R5 is selected from hydrogen and C1-C6 alkoxy;
- Ra is selected from C1-C6 alkylene;
- R8 is selected from NR9R10;
- and
- R9 and R10 are independently selected from H and C1-C6 alkyl, or R9 and R10 together with the nitrogen atom to which they are attached form a 4-8 membered heterocycle;
- with the proviso that R4 is —O—CH2—CH2—NCH3CH3 only if R5 is C1-C6 alkoxy.
8 more elements
A compound selected from the group consisting of:
- 4,4′-[2-(3-{[2-(Dimethylamino)ethyl]oxy}phenyl)-1-butene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(1-Piperidinyl)ethyl]oxy}phenyl)-1-hexene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(1-Pyrrolidinyl)ethyl]oxy}phenyl)-1-butene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(1-Piperidinyl)ethyl]oxy}phenyl)-1-butene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(Hexahydro-1H-azepin-1-yl)ethyl]oxy}phenyl)-1-butene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(dimethylamino)ethyl]oxy}phenyl)-1-pentene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(1-pyrrolidinyl)ethyl]oxy}phenyl)-1-pentene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(1-piperidinyl)ethyl]oxy}phenyl)-1-pentene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(dimethylamino)ethyl]oxy}phenyl)-1-hexene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(1-pyrrolidinyl)ethyl]oxy}phenyl)-1-hexene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(Hexahydro-1H-azepin-1-yl)ethyl]oxy}phenyl)-1-pentene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(Hexahydro-1H-azepin-1-yl)ethyl]oxy}phenyl)-1-hexene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(Dimethylamino)ethyl]oxy}phenyl)-1-heptene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(1-Pyrrolidinyl)ethyl]oxy}phenyl)-1-heptene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(1-Piperidinyl)ethyl]oxy}phenyl)-1-heptene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(Hexahydro-1H-azepin-1-yl)ethyl]oxy}phenyl)-1-heptene-1,1-diyl]diphenol;
- 4,4′-{2-[3-{[2-(Dimethylamino)ethyl]oxy}-4-(methyloxy)phenyl]-1-butene-1,1-diyl}diphenol;
- 4,4′-{2-[3-{[2-(Dimethylamino)ethyl]oxy}-4-(methyloxy)phenyl]-1-pentene-1,1-diyl}diphenol;
- 4,4′-{2-[3-{[2-(Dimethylamino)ethyl]oxy}-4-(methyloxy)phenyl]-1-hexene-1,1-diyl}diphenol;
- 4,4′-{2-[3-({2-[(3S)-3-Fluoro-1-pyrrolidinyl]ethyl}oxy)phenyl]-1-heptene-1,1-diyl}diphenol;
- 4,4′-[2-(3-{[2-(3,3-Difluoro-1-pyrrolidinyl)ethyl]oxy}phenyl)-1-heptene-1,1-diyl]diphenol;
- 4,4′-[2-(3-{[2-(1-Pyrrolidinyl)propyl]oxy}phenyl)-1-heptene-1,1-diyl]diphenol;
- and,
- 4,4′-[2-(3-{[2-(2-Methyl-1-pyrrolidinyl)ethyl]oxy}phenyl)-1-heptene-1,1-diyl]diphenol
- or a pharmaceutically acceptable salt or solvate thereof.
22 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.